BIS ETF Report: Ratings, Analysis, Quotes, Holdings

Popular BIS Comparisons: BIS vs SPXS, BIS vs SARK, BIS vs SPDN, BIS vs TZA, BIS vs SOXS

Find more ETFs with our ETF Screener and Database

*Unless otherwise stated, data provided by FactSet.

BIS Fund Description

BIS provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ.

BIS Factset Analytics Insight

BIS is one available fund that provides exposure to the biotech space — aiming for daily geared inverse (-2x) exposure to the NASDAQ Biotechnology Index (comprised of companies that are classified as either biotechnology or pharmaceutical). The fund expects to typically hold derivatives and money market instruments. Note: BIS is a tactical tool, it is not a buy-and-hold investment and should not be expected to provide index leverage returns greater than a one-day period.

PERFORMANCE [as of 05/20/22] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS

BIS 20.22% 5.45% 43.70% 33.98% -28.01% -23.47% -34.03%

BIS (NAV) 21.65% 7.46% 46.23% 30.22% -26.90% -23.22% -33.91%

NASDAQ Biotechnology Index -10.90% -6.75% -21.61% -22.25% 5.44% 4.59% 11.94%

N/A -- -- -- -- -- -- --

All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

BIS Summary Data

ProShares

04/07/10

Open-Ended Fund

0.95%

$8.92M

0.30%

N/A

Fund Home Page

BIS Portfolio Data

0.47%

N/A

BIS Index Data

NASDAQ Biotechnology Index

Market Cap

NASDAQ - Listed

N/A

BIS Fund Structure

Yes

-- / --

N/A

High

-2

Leverage Reset Frequency Daily

BIS Tax Exposures

20.00% / 39.60%

BIS Factset Analytics Block Liquidity

As of 05/24/22

This measurement shows how easy it is to trade a $1 million USD block of BIS. BIS is rated a N/A out of 5.

BIS Tradability

16,001

$446.46K

13,112

$326.80K

0.30%

$0.07

0.01%

1.58% / -1.13%

None

92.00%

50,000

0.26

0.03%

315

$29.37

N/A

The data and information contained herein is not intended to be investment or tax advice. A reference to a particular investment or security, a credit rating, or any observation concerning a security or investment provided in the ETF.com Service is not a recommendation to buy, sell, or hold such investment or security or to make any other investment decisions. You should not use such information for purposes of any actual transaction without consulting an investment or tax professional.

ETF.com DOES NOT TAKE RESPONSIBILITY FOR YOUR INVESTMENT OR OTHER ACTIONS NOR SHALL ETF.com HAVE ANY LIABILITY, CONTINGENT OR OTHERWISE, FOR THE ACCURACY, COMPLETENESS, TIMELINESS, OR CORRECT SEQUENCING OF ANY INFORMATION PROVIDED BY ETF.com OR FOR ANY DECISION MADE OR ACTION TAKEN BY YOU IN RELIANCE UPON SUCH INFORMATION OR ETF.com.

[ETF.com DOES NOT PROVIDE ANY RESEARCH OPINIONS.] ETF.com MAKES NO REPRESENTATIONS ABOUT THE SUITABILITY OF THE INFORMATION, PRODUCTS OR SERVICES CONTAINED HEREIN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.

Data provider:
Terms of Use

BIS